Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
about
Measurable residual disease testing in acute myeloid leukaemia.Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia.Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia.The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia.
P2860
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Multigene Measurable Residual ...... topoietic Cell Transplantation
@en
Multigene Measurable Residual ...... topoietic Cell Transplantation
@nl
type
label
Multigene Measurable Residual ...... topoietic Cell Transplantation
@en
Multigene Measurable Residual ...... topoietic Cell Transplantation
@nl
prefLabel
Multigene Measurable Residual ...... topoietic Cell Transplantation
@en
Multigene Measurable Residual ...... topoietic Cell Transplantation
@nl
P2093
P2860
P1476
Multigene Measurable Residual ...... topoietic Cell Transplantation
@en
P2093
Aaron C Logan
Brent L Wood
Charalambos Andreadis
Gabriel N Mannis
Jerald P Radich
Jimmy Hwang
Lloyd Damon
Nestor R Ramos
Thomas G Martin
P2860
P304
P356
10.1016/J.BBMT.2016.08.014
P577
2016-08-17T00:00:00Z